Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - Zynerba Pharmaceuticals, Inc. | a16-23198_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15 (d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): December 15, 2016
ZYNERBA PHARMACEUTICALS, INC.
(Exact Name of Issuer as Specified in Charter)
Delaware |
|
001-37526 |
|
26-0389433 |
(State or Other Jurisdiction of |
|
(Commission |
|
(I.R.S. Employer |
|
|
|
|
|
80 W. Lancaster Avenue, Suite 300
Devon, PA 19333
(Address of Principal Executive Offices)
(484) 581-7505
(Registrants Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
Attached as Exhibit 99.1 is a presentation that Zynerba Pharmaceuticals, Inc. (the Company) will use at its Clinical Research Day on December 15, 2016, starting at 8:00 am EST in New York City. The presentation and a live webcast of the event may be accessed through the Companys website and will be available for 90 days following the presentation.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit |
|
Document |
|
|
|
99.1 |
|
Zynerba Pharmaceuticals, Inc. Presentation. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 15, 2016
|
ZYNERBA PHARMACEUTICALS, INC. | |
|
|
|
|
By: |
/s/ Suzanne Hanlon |
|
|
Name: Suzanne Hanlon |
|
|
Title: Secretary, General Counsel and |